Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trialFrederick J. Raal, Stanley T. Crooke, Robin Lachmann et al.|The Lancet|2010Cited by 905
EP.12H.02 Amivantamab, An EGFR-MET Bispecific Antibody, with Cetrelimab, An Anti-PD-1 Antibody, In Advanced NSCLC: Phase 1/2 PolydamasP.J. Voon, B.C. Cho, Mehmet Alı Nahıt Şendur et al.|Journal of Thoracic Oncology|2024Cited by 1
Safety and Efficacy of Percutaneous Pulmonary Valve Implantation: The Singapore ExperienceFang Yi Lim, Ju Le Tan, Jie Sheng Foo et al.|Journal of Asian Pacific Society of Cardiology|2024Cited by 0